310 related articles for article (PubMed ID: 21272192)
21. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.
Wang SW; Wang YJ; Su YJ; Zhou WW; Yang SG; Zhang R; Zhao M; Li YN; Zhang ZP; Zhan DW; Liu RT
Neurotoxicology; 2012 Jun; 33(3):482-90. PubMed ID: 22445961
[TBL] [Abstract][Full Text] [Related]
22. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
23. Norepinephrine provides short-term neuroprotection against Aβ1-42 by reducing oxidative stress independent of Nrf2 activation.
Jhang KA; Lee EO; Kim HS; Chong YH
Neurobiol Aging; 2014 Nov; 35(11):2465-2473. PubMed ID: 24954831
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.
Ansari MA; Abdul HM; Joshi G; Opii WO; Butterfield DA
J Nutr Biochem; 2009 Apr; 20(4):269-75. PubMed ID: 18602817
[TBL] [Abstract][Full Text] [Related]
25. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
[TBL] [Abstract][Full Text] [Related]
26. The link between altered cholesterol metabolism and Alzheimer's disease.
Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
[TBL] [Abstract][Full Text] [Related]
27. Genistein alleviates the mitochondria-targeted DNA damage induced by β-amyloid peptides 25-35 in C6 glioma cells.
Ma WW; Hou CC; Zhou X; Yu HL; Xi YD; Ding J; Zhao X; Xiao R
Neurochem Res; 2013 Jul; 38(7):1315-23. PubMed ID: 23519932
[TBL] [Abstract][Full Text] [Related]
28. ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures.
Kuperstein F; Yavin E
Eur J Neurosci; 2002 Jul; 16(1):44-54. PubMed ID: 12153530
[TBL] [Abstract][Full Text] [Related]
29. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity.
Chonpathompikunlert P; Han J; Toh K; Isoda H; Nagasaki Y
Eur J Pharmacol; 2011 Jan; 650(2-3):544-9. PubMed ID: 20969847
[TBL] [Abstract][Full Text] [Related]
30. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against Aβ(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals.
Chen TF; Tang MC; Chou CH; Chiu MJ; Huang RF
Food Chem Toxicol; 2013 Dec; 62():538-47. PubMed ID: 24055771
[TBL] [Abstract][Full Text] [Related]
31. Genistein and folic acid prevent oxidative injury induced by β-amyloid peptide.
Ding B; Yuan L; Yu H; Li L; Ma W; Bi Y; Feng J; Xiao R
Basic Clin Pharmacol Toxicol; 2011 May; 108(5):333-40. PubMed ID: 21205217
[TBL] [Abstract][Full Text] [Related]
32. H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK.
Tamagno E; Robino G; Obbili A; Bardini P; Aragno M; Parola M; Danni O
Exp Neurol; 2003 Apr; 180(2):144-55. PubMed ID: 12684028
[TBL] [Abstract][Full Text] [Related]
33. N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid β-induced neuronal oxidative damage in cortical neurons.
Cho CH; Kim EA; Kim J; Choi SY; Yang SJ; Cho SW
Free Radic Res; 2016 Jun; 50(6):678-90. PubMed ID: 27002191
[TBL] [Abstract][Full Text] [Related]
34. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease.
Akterin S; Cowburn RF; Miranda-Vizuete A; Jiménez A; Bogdanovic N; Winblad B; Cedazo-Minguez A
Cell Death Differ; 2006 Sep; 13(9):1454-65. PubMed ID: 16311508
[TBL] [Abstract][Full Text] [Related]
35. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
Atwood CS; Obrenovich ME; Liu T; Chan H; Perry G; Smith MA; Martins RN
Brain Res Brain Res Rev; 2003 Sep; 43(1):1-16. PubMed ID: 14499458
[TBL] [Abstract][Full Text] [Related]
37. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
Verdier Y; Zarándi M; Penke B
J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
[TBL] [Abstract][Full Text] [Related]
38. Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity.
Lecanu L; Yao W; Teper GL; Yao ZX; Greeson J; Papadopoulos V
Steroids; 2004 Jan; 69(1):1-16. PubMed ID: 14715372
[TBL] [Abstract][Full Text] [Related]
39. Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity.
Angelova PR; Abramov AY
Biochem Soc Trans; 2014 Oct; 42(5):1286-90. PubMed ID: 25233405
[TBL] [Abstract][Full Text] [Related]
40. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
Jana A; Pahan K
J Biol Chem; 2004 Dec; 279(49):51451-9. PubMed ID: 15452132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
